Publicaciones en las que colabora con María Buti Ferret (9)

2024

  1. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

    Journal of Hepatology, Vol. 80, Núm. 2, pp. 232-242

  2. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics

2023

  1. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    The Lancet Gastroenterology and Hepatology, Vol. 8, Núm. 10, pp. 879-907

  2. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

    Journal of Hepatology

  3. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 8, pp. 594-602

  4. Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 3, pp. 128-132

  5. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

  6. Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

    Digestive Diseases and Sciences, Vol. 68, Núm. 6, pp. 2731-2737

2020

  1. Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)

    Gastroenterologia y Hepatologia, Vol. 43, Núm. 9, pp. 559-587